Centers | ||
|
|
|
Drug Discovery Core | VMCC, University of Michigan | Therapeutic Accelerator Program (TAP) |
The Drug Discovery Core at the University of Utah is an established Service/Recharge center that provides compound collections for screening by University of Utah Faculty. Our mission is to provide customers low-cost and efficient access to chemical... |
The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations. Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into... |
Test |
Partnerships |
Events |
Jobs |
Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage ObesityAstra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage obesity, control glucose and lipid metabolism in... View all Vanderbilt and GSK Partner to Develop Therapies to Treat ObesityVanderbilt University and GSK have entered into partnership to develop drugs to treat Obesity. GSK will provide funding support to Vanderbilt for three years. View all Roche to Collaborate with UCSD ScientistsRoche and UC San Diego have established UC San Diego-Roche Extending Innovation Network (EIN) program. The program aims to accelerate drug discovery development through joint collaboration and leveraging academic and industry expertise. Under this... View all |
No EVENTS for listing |
No Job Posts |
